| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Apr 3, 2014 | Neurovance | Series A | — | Biotechnology | — |
| Mar 1, 2013 | CardioKinetix | Series E | — | Biotechnology | — |
| Jan 8, 2013 | Labcyte | Series D | — | Alternative Medicine | — |
| Oct 18, 2012 | Neurovance | Series Unknown | — | Biotechnology | — |
| Oct 5, 2011 | Puma Biotechnology | Post-IPO Equity | — | Biotechnology | — |
| Aug 4, 2008 | PHT Corporation | Series F | — | Clinical Trials | — |
| Mar 1, 2004 | CardioNet | Series D | — | Biotechnology | — |
| Oct 2, 2003 | PHT Corporation | Series E | — | Clinical Trials | — |
| Oct 30, 2001 | Therion Biologics | Series Unknown | — | Biotechnology | — |
| Jun 20, 2000 | Acadia Pharmaceuticals Inc. | Debt Financing | — | Biotechnology | Yes |